Home Posts tagged XCath

XCath

NEWS DESK

XCath Secures $30 Million Series C to Improve Global Outcomes in Neurovascular Care

XCath, a medical device company that is pioneering neuro-endovascular surgical robotics, part owned by Crescent Enterprises, announced today that it has secured $30 million in Series C funding, bringing the total raised since the company’s inception to $92 million. The latest funds will support XCath’s ongoing efforts to bring the world’s first commercially-practical
NEWS DESK

Successful World-First Robotic Brain Surgery

XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, and Crescent Enterprises, the founding and largest shareholder of XCath, have announced the successful first-in-human use of XCath’s EVR robotic system to treat three patients with complex brain aneurysms. The landmark procedures were performed at The Panama Clinic in Panama City,